Incyte INCY
NASDAQ INCY
$126.75 -1.25 (-0.98%)
As of: Sep 4, 2026 · 3:59 PM EDT

Incyte (INCY) Buildings (2018)

Incyte's (INCY) quarterly Buildings came in at $37.5 million in Q4 2018.

Analysis

Incyte (INCY) Buildings (2018) Analysis & Trends

Incyte (INCY) has 1 years of Buildings data on file, last reported at $37.5 million in Q4 2018.

  • Quarterly Buildings changed N/A year-over-year to $37.5 million in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $37.5 million (changed N/A YoY) and the FY2018 annual result came in at $37.5 million, changed N/A from the prior year.
  • Buildings steadied at $37.5 million in Q4 2018.
  • In the past five years, Buildings ranged from a high of $37.5 million in Q4 2018 to a low of $37.5 million in Q4 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Incyte 25.44 Bn 20.91 Bn 1.57 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 37.50 Mn